|
US2010210546A1
|
|
Combination chemotherapy with chlorotoxin
|
|
CN102438646A
|
|
Treatment of metastatic tumors
|
|
WO2009140599A1
|
|
Treatment of metastatic tumors
|
|
AU2008310664A1
|
|
Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
|
|
CA2718854A1
|
|
Inhibition of angiogenesis
|
|
CA2696303A1
|
|
Chlorotoxins as drug carriers
|
|
WO2007117467A2
|
|
Use of tm-601 for the diagnosis and treatment of tumors
|
|
CA2561494A1
|
|
Diagnosis and treatment of myeloid and lymphoid cell cancers
|
|
US2008153746A1
|
|
Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers
|
|
US2007275902A1
|
|
Treatment of Phosphatidylinositol Phospholipid Disorders
|
|
WO03101474A1
|
|
Combination chemotherapy with chlorotoxin
|
|
AU2003215015A1
|
|
Recombinant expression vectors for functional nav1.9 sodium channels
|
